<DOC>
	<DOCNO>NCT00245336</DOCNO>
	<brief_summary>The purpose study determine whether recombinant human Thrombin ( rhThrombin ) effective stop bleeding surgery , comparison bovine thrombin .</brief_summary>
	<brief_title>Study Recombinant Human Thrombin Bleeding During Surgery</brief_title>
	<detailed_description>This Phase 3 multiple site , randomize , double-blind , control trial design evaluate comparative efficacy safety rhThrombin bovine thrombin patient undergoing spinal surgery , hepatic resection , peripheral arterial bypass surgery , arteriovenous graft formation hemodialysis access . After establish eligibility , subject randomized 1:1 ratio receive rhThrombin ( 1000 U/mL ) bovine thrombin ( 1000 U/mL ) . During surgical procedure , study participant treat blinded study drug ( rhThrombin bovine thrombin ) combination absorbable gelatin sponge appropriate bleeding evaluation site ( ) time hemostasis ( TTH ) assess 10 minute . Bleeding appropriate TTH evaluation define mild moderate bleeding , either remain brisk bleed control standard surgical modality . Blinded study drug may also use additional appropriate bleeding site . Study participants follow-up visit 2 day 1 month surgery . Approximately 400 600 patient participate study . The final sample size determine base blind interim result .</detailed_description>
	<mesh_term>Thrombin</mesh_term>
	<mesh_term>Gelatin Sponge , Absorbable</mesh_term>
	<criteria>Subject undergo spinal surgery , hepatic resection , peripheral arterial bypass surgery , arteriovenous graft formation hemodialysis access Subject undergone therapeutic surgical procedure within 30 day prior surgery Subject history heparininduced thrombocytopenia Subject know antibody hypersensitivity thrombin coagulation factor know sensitivity component study treatment Subject receive blood product within 24 hour prior surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>hemostasis</keyword>
	<keyword>surgery</keyword>
	<keyword>hemostatics</keyword>
	<keyword>randomize control trial</keyword>
	<keyword>phase 3</keyword>
</DOC>